Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...

A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...

Are weight loss-approved injectable right for you? On this episode of MorningLine, Nick Bere is joined by Dr. Calvin Smith ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...

The beverage giant is ready to manage, mitigate and adjust to the “dynamic macro environment,” including potential tariffs ...

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

Ryals McMullian noted consumers are moving away from traditional white and wheat bread into organic, keto, gluten-free and ...

Boone Health is closing its bariatric clinic in Columbia because of lagging demand. "We're working to expand the high-demand ...

Sodium-glucose cotransporter 2, or SGLT2, inhibitors and glucagon-like peptide-1 receptor agonists lowered the risk for COPD exacerbation in adults with the disease and type 2 diabetes, researchers ...

A small number of patients using GLP-1 weight loss medications have experienced vision loss, although researchers have not ...